Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Noribogaine is a G-protein biased κ-opioid receptor agonist - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Opioid Receptors - Pharmacology
Opioid Receptor | kappa, mu Opioid Receptor
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Buprenorphine: A Promising Yet Overlooked Tool
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Mu Opiate Receptor Agonist - an overview | ScienceDirect Topics
Opioid Receptor Binding Affinities of Dynorphin Analogues. | Download Table
Opioid Receptor Binding Affinities of Dynorphin Analogues. | Download Table
κ-opioid receptor - Wikipedia
Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
κ-opioid receptor - Wikipedia
Innovation – Cara Therapeutics
Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking | PLOS ONE
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics